Pages that link to "Q47952891"
Jump to navigation
Jump to search
The following pages link to Combined OX40L and mTOR blockade controls effector T cell activation while preserving Treg reconstitution after transplant (Q47952891):
Displaying 15 items.
- Biomarkers for post-transplantation outcomes. (Q52603913) (← links)
- CD28 blockade controls T cell activation to prevent graft-versus-host disease in primates (Q56889641) (← links)
- Regulatory T cells in the treatment of disease (Q57471979) (← links)
- Evidence for persistence of the SHIV reservoir early after MHC haploidentical hematopoietic stem cell transplantation (Q58561116) (← links)
- Angela Panoskaltsis-Mortari (Q60452140) (← links)
- Defining success with cellular therapeutics: the current landscape for clinical end point and toxicity analysis (Q88573546) (← links)
- Post-haematopoietic cell transplantation outcomes: why ST2 became a 'golden nugget' biomarker (Q89624476) (← links)
- Transplantation: Combining OX40L and mTOR blockade (Q89763257) (← links)
- Exploiting immunometabolism and T cell function for solid organ transplantation (Q90080933) (← links)
- Transplant research in nonhuman primates to evaluate clinically relevant immune strategies in organ transplantation (Q91554792) (← links)
- Local Delivery of Regulatory T Cells Promotes Corneal Allograft Survival (Q91681739) (← links)
- The promise of CD4+FoxP3+ regulatory T-cell manipulation in vivo: applications for allogeneic hematopoietic stem cell transplantation (Q92916933) (← links)
- Central Roles of OX40L-OX40 Interaction in the Induction and Progression of Human T Cell-Driven Acute Graft-versus-Host Disease (Q93031404) (← links)
- Biomarkers for Allogeneic HCT Outcomes (Q94561571) (← links)
- Targeting co-stimulatory molecules in autoimmune disease (Q99557580) (← links)